Dae Ho Lee

Featured in: Favicon

nature.com Favicon

jamanetwork.com Favicon

thelancet.com Favicon

jdsupra.com Favicon

amazon.science Favicon

chaindrugreview.com Favicon

diabetesresearchclinicalpractice.com Favicon

lungcancerjournal.info Favicon

onlinelibrary.wiley.com

Articles

Buchanan Adds Life Sciences Shareholder in New Jersey

Jan 6, 2025 | bipc.com | Dae Ho Lee

Newark, New Jersey (January 2025) - Buchanan Ingersoll & Rooney continues its strategic expansion with the addition of Dae Y. Lee, Pharm.D., CPBS as a shareholder in Newark. He joins the FDA & Biotechnology section focusing on representing pharmacies and stakeholders in the pharmacy industry.
Epidemiology and Outcomes of Non-Small Cell Lung Cancer in South Korea

Feb 9, 2024 | jamanetwork.com | Hyun Jung |Dae Ho Lee |Yonsei College

Key PointsQuestion Has overall survival (OS) of patients with non–small cell lung cancer (NSCLC) improved in recent years in clinical practice? Findings This cohort study of 22 101 patients with NSCLC found that increased targeted therapy use for patients with nonsquamous cancer with EGFR sequence variants or ALK rearrangement in period 2 (2017-2019) was associated with better OS than for similar patients in period 1 (2014-2016).

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →